Retatrutide

Price range: £157.95 through £180.00

A synthetic peptide agonist of the GIP, GLP-1 and glucagon receptors, studied in metabolic and energy-balance research models.

Batch-identified product
Certificate of purity where applicable
Insured shipping across India
Secure UPI & card payments

For research purposes only. NEXCELL products are not medicines and are not intended for human consumption, diagnosis, treatment, cure or prevention of disease.

SKU: NX-RETATRUTIDE Category:

Description

A synthetic peptide agonist of the GIP, GLP-1 and glucagon receptors, studied in metabolic and energy-balance research models.

Formats

Available as a lyophilised-powder vial for reconstitution in the lab, or as a NEXCELL research pen: a sealed, pre-filled format that removes the need for separate reconstitution and keeps research handling organised. Each pen is supplied in a protective NEXCELL presentation box. The pen holds 40 mg of retatrutide in total.

Storage

Store refrigerated between 2 °C and 8 °C. Protect from direct light and excessive heat. Do not freeze. Keep sealed in the original packaging until required for legitimate laboratory research.

Product status

Retatrutide is an investigational compound and is not currently an approved medicine in the United Kingdom. It must not be presented as an approved treatment for any medical condition.

For research purposes only. NEXCELL products are not medicines and are not intended for human consumption, diagnosis, treatment, cure or prevention of disease.

Batch documentation for this product is available on request. Contact us with your order number.

Additional information

Format

Vial, Pen

Amount

10 mg, 40 mg

Store sealed vials at 2–8 °C for short-term use or −20 °C for long-term storage, away from light. After reconstitution, keep at 2–8 °C and avoid repeated freeze–thaw cycles.